Arabic Arabic English English French French German German
dark

Public Meeting on Patient Focused Drug Development for Non Tuberculous Mycobacterial Infections Pt 1

On October 15, 2015, FDA hosted a public meeting on Patient-Focused Drug Development for Non-Tuberculous Mycobacterial Lung Infections. FDA was interested in obtaining patient perspectives on the impact of Non-Tuberculous Mycobacterial Lung Infections on daily life and patient views on treatment approaches. For more information, visit https://go.usa.gov/xH5H8.

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Public Meeting on Patient Focused Drug Development for Non Tuberculous Mycobacterial Infections Pt 2

Next Post

What to expect at your COVID-19 vaccination appointment

Related Posts
Total
0
Share